Polyana Bastos joined Johnson & Johnson (J&J) in July 2017 through the acquisition of Actelion Pharmaceuticals Ltd. Since then, Polyana has been providing regulatory legal support on a wide range of research and development matters and policies, including bioresearch quality, pre-approval access and clinical data transparency, advising on J&J’s data transparency strategy and related operationalization of regulatory requirements.

Polyana is responsible for the legal support of J&J’s Clinical Trial Data Transparency Initiative, including the Yale University Open Data Access (YODA) Project data sharing collaboration. She serves as a clinical data transparency subject matter expert for various internal and external policy work, advises on J&J’s transition into the EU Clinical Trials Regulation serving as member of the EU CTR Steering Committee and EU CTR Change Management Team.
Polyana represents J&J in the Clinical Trial Transparency arm of the EFPIA Clinical Research Expert Group.